Cargando…
Biomimetic Nanocarriers for Cancer Target Therapy
Nanotechnology offers innovative tools for the design of biomimetic nanocarriers for targeted cancer therapy. These nano-systems present several advantages such as cargo’s protection and modulation of its release, inclusion of stimuli-responsive elements, and enhanced tumoral accumulation. All toget...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552783/ https://www.ncbi.nlm.nih.gov/pubmed/32937963 http://dx.doi.org/10.3390/bioengineering7030111 |
_version_ | 1783593477517344768 |
---|---|
author | Guido, Clara Maiorano, Gabriele Cortese, Barbara D’Amone, Stefania Palamà, Ilaria Elena |
author_facet | Guido, Clara Maiorano, Gabriele Cortese, Barbara D’Amone, Stefania Palamà, Ilaria Elena |
author_sort | Guido, Clara |
collection | PubMed |
description | Nanotechnology offers innovative tools for the design of biomimetic nanocarriers for targeted cancer therapy. These nano-systems present several advantages such as cargo’s protection and modulation of its release, inclusion of stimuli-responsive elements, and enhanced tumoral accumulation. All together, these nano-systems suffer low therapeutic efficacy in vivo because organisms can recognize and remove foreign nanomaterials. To overcome this important issue, different modifications on nanoparticle surfaces were exploited in order to reach the desired therapeutic efficacy eliciting, also, the response of immune system against cancer cells. For this reason, more recently, a new strategy involving cell membrane-covered nanoparticles for biomedical application has been attracting increasing attention. Membranes from red blood cells, platelets, leukocytes, tumor, and stem cells, have been exploited as biomimetic coatings of nanoparticles for evading clearance or stimulated immune system by maintaining in the same way their targeting capability. In this review, the use of different cell sources as coating of biomimetic nanocarriers for cancer therapy is discussed. |
format | Online Article Text |
id | pubmed-7552783 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75527832020-10-19 Biomimetic Nanocarriers for Cancer Target Therapy Guido, Clara Maiorano, Gabriele Cortese, Barbara D’Amone, Stefania Palamà, Ilaria Elena Bioengineering (Basel) Review Nanotechnology offers innovative tools for the design of biomimetic nanocarriers for targeted cancer therapy. These nano-systems present several advantages such as cargo’s protection and modulation of its release, inclusion of stimuli-responsive elements, and enhanced tumoral accumulation. All together, these nano-systems suffer low therapeutic efficacy in vivo because organisms can recognize and remove foreign nanomaterials. To overcome this important issue, different modifications on nanoparticle surfaces were exploited in order to reach the desired therapeutic efficacy eliciting, also, the response of immune system against cancer cells. For this reason, more recently, a new strategy involving cell membrane-covered nanoparticles for biomedical application has been attracting increasing attention. Membranes from red blood cells, platelets, leukocytes, tumor, and stem cells, have been exploited as biomimetic coatings of nanoparticles for evading clearance or stimulated immune system by maintaining in the same way their targeting capability. In this review, the use of different cell sources as coating of biomimetic nanocarriers for cancer therapy is discussed. MDPI 2020-09-14 /pmc/articles/PMC7552783/ /pubmed/32937963 http://dx.doi.org/10.3390/bioengineering7030111 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Guido, Clara Maiorano, Gabriele Cortese, Barbara D’Amone, Stefania Palamà, Ilaria Elena Biomimetic Nanocarriers for Cancer Target Therapy |
title | Biomimetic Nanocarriers for Cancer Target Therapy |
title_full | Biomimetic Nanocarriers for Cancer Target Therapy |
title_fullStr | Biomimetic Nanocarriers for Cancer Target Therapy |
title_full_unstemmed | Biomimetic Nanocarriers for Cancer Target Therapy |
title_short | Biomimetic Nanocarriers for Cancer Target Therapy |
title_sort | biomimetic nanocarriers for cancer target therapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552783/ https://www.ncbi.nlm.nih.gov/pubmed/32937963 http://dx.doi.org/10.3390/bioengineering7030111 |
work_keys_str_mv | AT guidoclara biomimeticnanocarriersforcancertargettherapy AT maioranogabriele biomimeticnanocarriersforcancertargettherapy AT cortesebarbara biomimeticnanocarriersforcancertargettherapy AT damonestefania biomimeticnanocarriersforcancertargettherapy AT palamailariaelena biomimeticnanocarriersforcancertargettherapy |